Antimicrobial peptides and peptaibols, substitutes for conventional antibiotics

Current Pharmaceutical Design

Volumn 16, Issue 28, 2010, Pages 3212-3223

  Duclohier, Hervé ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Alamethicin; Antimicrobial peptides; Peptaibols; Planar lipid bilayers

Indexed keywords

ALAMETHICIN; AMPHOTERICIN A; AMPHOTERICIN B; ANTIAMEBIC AGENT; ANTIBIOTIC AGENT; BOMBININ; BREVININ; CECROPIN A; CECROPIN B; CECROPIN D; CYCLOPEPTIDE; DEFENSIN; DERMASEPTIN; ESCULLENTIN; GAEGURIN; GAEGURIN 4; GRAMICIDIN; HARZIANIN; MAGAININ DERIVATIVE; MELITTIN; MONAZOMYCIN; NATURAL PRODUCT; NYSTATIN; PEPTAIBOL; POLYPEPTIDE ANTIBIOTIC AGENT; SUZUKACILLIN; TEMPORIN; TRICHORZIANIN; TRICHOTOXIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CHRONIC RHINOSINUSITIS; CYTOTOXICITY; DRUG POTENCY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYDROPHOBICITY; LIPID BILAYER; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL MEMBRANE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; PEPTAIBOLS; PEPTIDES;

EID: 78649814077     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793292500     Document Type: Review

References (154)

1. Levin AS. Nosocomial legionellosis: prevention and management. Expert Rev Anti Infect Ther 2009; 7: 57-68.
2. Vuong C, Otto M. Staphylococcus epidermidis infections. Microb Infect 2002; 4: 481-9.
3. Chusri S, Villanueva I, Voravuthikunchai SP, Davies J. Enhancing antibiotic activity: a strategy to control Actinobacter infections. J Antimicrob Chemotherapy 2009; 64: 1203-11.
4. Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin 2009; 25: 733-51.
5. Botrem MA, Haenni M, Morignat E, Sulpice P, Madec JY, Calavas D. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France. Foodborne Pathogens Dis 2010; 7: 479-87.
6. Foley EJ, Lee SW. Observations on antibiotic coaction of gramicidin and penicillin on streptococci and staphylococci in vitro. J Immunol 1948; 58: 203-9.
7. Mogi T, Kita K. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol Life Sci 2009; 66(23): 3821-6.
8. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007; 64: 922-33.
9. Hancock RE, Sahl HG. Antimicrobial and host-defence peptides as new antiinfective therapeutic strategies. Nat Biotechnol 2006; 24: 1551-7.
10. Huang HW. Molecular mechanisms of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 2006; 1758: 1292-1302.
11. Shai Y, Makovitzky A, Avrahami D. Host defense peptides and lipopeptides: modes of action and potential candidates for the treatment of bacterial and fungal infections. Curr Protein Pept Sci 2006; 7: 479-86.
12. Duclohier H. How do channel- and pore-forming helical peptides interact with lipid membranes and how does this account for their antimicrobial activity. Mini-Rev Med Chem 2002; 2: 331-42.
13. Cantor R.S. Size distribution of barrel-stave aggregates of membrane peptides: influence of the bilayer lateral pressure profile. Biophys J 2002; 82: 2520-5.
14. Hotchkiss RD, Dubos RJ. Fractionation of the bactericidal agent from cultures of a soil bacillus. J Biol Chem 1940; 132: 791-2.
15. Wallace BA, Ravikumar K. The gramicidin pore: crystal structure of a cesium complex. Science 1988; 241: 182-7.
16. Smart OS, Goodfellow JM, Wallace BA. The pore dimensions of Gramicidin A. Biophys J 1993; 65: 2455-60.
17. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987; 84: 5449-53.
18. Cruciani RA, Barker JL, Zasloff M, Chen H-C, Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 1991; 88: 3792-6.
19. Matsuzaki K, Murase O, Tokuda H, Funakoshi S, Fujii N, Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 1994; 33: 3342-9.
20. Duclohier H, Molle G, Spach G. Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophys J 1989; 56: 1017-
21. Cruciani RA, Barker JL, Durell SR, et al. Magainin 2, a natural antibiotic from frog skin, forms ion channels in lipid bilayer membranes. Eur J Pharmacol 1992; 226: 287-96.
22. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainins. Biochemistry 1996; 35: 13723-8.
23. Amiche M, Ducancel F, Lajeunesse E, Boulain JC, Ménez A, Nicolas P. Molecular cloning of a cDNA encoding the precursor of adenoregulin from frog skin. Relationships with the vertebrate defensive peptides, dermaseptins. Biochem Biophys Res Commun 1993; 191: 983-90.
24. Nicolas P, El Amri C. The dermaseptin superfamily: a gene-based combinatorial library of antimicrobial peptides. Biochim Biophys Acta 2009; 1788: 1537-50.
25. Auvynet C, Joanne P, Bourdais J, Nicolas P, Lacombe C, Rosenstein Y. Dermaseptin DA4, although closely related related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities. FEBS J 2009; 276: 6773-86.
26. Feder R, Dagan A, Mor A. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytoxicity. J Biol Chem 2000; 275: 4230-8.
27. Duclohier H. Bilayer lipid composition modulates the activity of dermaseptins, polycationic antimicrobial peptides. Eur Biophys J 2006; 35: 401-9.
28. Fisher FG, Neumann WP. The venom of the honeybee.III. On the chemical knowledge of the principle active constituent (melittin). Biochem Z 1961; 335: 51-61.
29. Machan R, Miszta A, Hermes W, Hof M. Real-time monitoring of melittin-induced pore formation and tubule formation from supported lipid bilayers and its physiological relevance. Chem Phys Lipids 2009; 163: 200-6.
30. Clague MJ, Cherry RJ. A comparative study of band 3 aggregation in erythrocyte membranes by melittin and other cationic agents. Biochim Biophys Acta 1989; 980: 93-9.
31. Homble F, Cabiaux V, Ruysschaert JM. Channel or channel-like activity associated with pore-forming proteins or peptides? Mol Microbiol 1998; 27: 1261-63.
32. Terwilliger TC, Weissman L, Eisenberg, D. The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities. Biophys J 1982; 37: 353-61.
33. Tosteson MT, Tosteson DC. The sting. Melittin forms channels in lipid bilayers. Biophys J 1981; 36: 109-16.
34. Hanke W, Methfessel C, Wilmsen H.U, Katz E, Jung G, Boheim G. Melittin and a chemically modified trichotoxin form alamethicintype multi-state pores. Biochim Biophys Acta 1983; 727: 108-14.
35. Manna M, Mukhopadhyay C. Cause and effect of melittin-induced pore formation: a computational approach. Langmuir 2009; 25: 12235-42.
36. Vitale N, Thiersé D, Bader MF. Melittin promotes exocytosis in neuroendocrine cells through the activation of phospholipase A(2). Regul Pept 2009 (in Press).
37. Boman HG, Hultmark D. Cell-free immunity in insects. Annu Rev Microbiol 1987; 41: 103-26.
38. Pillai A, Ueno S, Zhang H, Lee JM, Kato Y. Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode ascaris suum. Biochem J 2005; 390: 207-14.
39. Otvos L, Jr. Antibacterial peptides isolated from insects. J Pept Sci 2000; 6: 497-511.
40. Suttmann H, Retz M, Paulsen F, et al. Antimicrobial peptides of the cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol 2008; 8: 5.
41. Chen X, Zhu F, Cao Y, Qiao S. Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity. Antimicrob Agents Chemother 2009; 53: 3683-9.
42. Park JM, Jung JE, Lee BJ. Antimicrobial peptides from the skin of a korean frog, Rana rugosa. Biochem Biophys Res Commun 1994; 205: 948-4.
43. Won HS, Kang SJ, Lee BJ. Action mechanism and structural requirements of the antimicrobial peptides, gaegurins. Biochim Biophys Acta 2009; 1788: 1620-9.
44. Chi SW, Kim JS, Kim DH, Lee SH, Park YH, Han KH. Solution structure and membrane interaction of an antimicrobial peptide, gaegurin 4. Biochem Biophys Res Commun 2007; 352: 592-7.
45. Kim HJ, Han SK, Park JB, Ryu PD, Baek HJ, Lee JB. Gaegurin 4, a peptide antibiotic of frog skin, forms voltage-dependent channels in planar lipid bilayers. J Peptide Res 2007; 53: 1-7.
46. Simmaco M, Mignogna G, Barra D, Bossa F. Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevenins and isolation of new active peptides. J Biol Chem 1994; 269: 11956-61.
47. Marenah L, Flatt PR, Orr DF, Shaw C, Abdel-Wahab YH. Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevenins-1E, and -2EC with novel insulin releasing activity. J Endocrinol 2006; 188: 1-9.
48. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D. Temporins, antimicrobial peptides from the european frog Rana temporaria. Eur J Biochem 1996; 242: 788-792.
49. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D, Simmaco M. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 2000; 267: 1447-54.
50. Kim JB, Halverson T, Basir YJ, et al. Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the north american pig frog Rana grylio. Regul Peptides 2000; 90: 53-60.
51. Mahalka AJ, Kinnunen PKJ. Binding of amphipathic α-helical antimicrobial peptides to lipid membranes: lessons from temporins B and L. Biochim Biophys Acta 2009; 1788: 1600-9.
52. Saviello MR, Malfi S, Cavalli A, Grieco P, Novellino E, Carotenuto A. New insight into the mechanism of action of the temporins antimicrobial peptides. Biochemistry 2010; 49(7): 1477-85.
53. Roseghini M, Falconieri Erspamer G, Severini C, Simmaco M. Biogenic amine and active peptides in extracts of the skin of thirtytwo European amphibian species. Comp Biochem Physiol C 1989; 94: 455-60.
54. Miele R, Ponti D, Boman HG, Barra D, Simmaco M. Molecular cloning of a bombinin gene from Bombina orientalis: detection of NF-kB and NF-IL6 binding sites in its promoter. FEBS Lett 1998; 431: 23-8.
55. Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D. Structurefunction relationships in bombinins H, antimicrobial peptides from Bombina skin secretions. Peptides 2000; 21: 1673-9.
56. Simmaco M, Kreil G, Barra D. Bombinins, antimicrobial peptides from Bombina species. Biochim Biophys Acta 2009; 1788: 1551-5.
57. Lambert J, Keppi E, Dimarcq JL, et al. Insect immunity: isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bacterial peptides. Proc Natl Acad Sci USA 1989; 86: 262-6.
58. Bonmatin JM, Bonnat JL, Gallet X, et al. Two-dimensional 1H NMR study of recombinant insect defensin A in water: resonance assignments, secondary structure and global folding. J Biomol NMR 1992; 2: 235-56.
59. McManus AM, Dawson NF, Wade JD, Carrington LE, Winzor DJ, Craik DJ. Three-dimensional structure of RK-1: a novel alphadefensin peptide. Biochemistry 2000; 39: 15757-64.
60. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-50.
61. Lehrer RI, Ganz T. Defensins: endogenous antibiotic peptides from human leukocytes. Ciba Found Symp 1992; 171: 276-90.
62. Kourie JI, Shorthouse AA. Properties of cytotoxic peptide-formed channels. Am J Physiol Cell Physiol 2000; 278: C1063-87
63. Aszalos A, Bax A, Burlinson N, Roller P, MacNeal C. Physicochemical and microbiological comparison of nystatin, amphotericin A and amphotericin B, and structure of amphotericin A. J Antibiot (Tokyo) 1985; 38: 1699-713.
64. MacNall EG, Halde C, Newcomer VD, Sternberg TH. A biological assay for the determination of amphotericin A and B in biological fluids. Antibiot Ann 1957; 5: 131-136.
65. Monji N, Mechlinski W, Schaffner CP. (1976). Microbial production of amphotericin B-3H and the synthesis of its sodium desoxycholate (carboxyl-14C) complex and methyl-14C-ester. J Antibiot (Tokyo) 1976; 29: 438-43.
66. Jornot L, Rochat T, Caruso A, Lacroix JS. Effects of amphotericin B on ion transport in airway epithelial cells. J Cell Physiol 2005; 204: 859-70.
67. Semis S, Polachnek I, Segal E. Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and moulds. Mycopathologia 2010; 169(5): 333-41.
68. Marty A, Finkelstein A. Pores formed in lipid bilayer membranes by nystatin, differences in its one-sided and two-sided action. J Gen Physiol 1975; 65: 515-26.
69. Kleinberg ME, Finkelstein A. Single-length and double-length channels formed by nystatin in lipid bilayer membranes. J Membrane Biol 1984; 80: 257-69.
70. Brutian RA. Ion channels induced by amphotericin N introduced unilaterally into lipid bilayers. Biofizika 1982; 27: 646-9.
71. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties. Biochim Biophys Acta 1986; 864: 257-304.
72. Vertut-Doi A, Hannaert P, Bolard J. The polyene antibiotic amphotericin B inhibits the Na+/K+ pump of human erythrocytes. Biochem Biophys Res Commun 1988; 157: 692-7.
73. Bonilla-Marin M, Morello-Bello M, Ortega-Blake I. A microscopic electrostatic model for the amphotericin B channel. Biochim Biophys Acta 1991; 1061: 65-77.
74. Akaike N, Harata N. Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn J Physiol 1994; 44: 433-73.
75. Degenkolb T, Brückner H. Peptaibiomics: towards a myriad of bioactive peptides containing C α - dialkylamino acids. In: Peptaibiotics, fungal peptides containing α-dialkyl α -amino acids. (Toniolo C, Brückner H, Eds. Weinheim: Verlag Helvetica Chimica Acta, Zürich, and Wiley-VCH 2009; pp. 3-29.
76. Brückner H, Becker D, Gams W, Degenkolb T. Aib and Iva in the biosphere: neither rare nor necessarily extraterrestrial. Chem Biodivers 2009; 6: 38-56.
77. Meyer CE, Reusser F. A polypeptide antibacterial agent isolated from Trichoderma viride. Experientia 1967; 23: 85-6.
78. Rinehart KL Jr, Cook JC, Meng H, Olson KL, Pandey RC. Mass spectrometric determination of molecular formulas for membranemodifying antibiotics. Nature 1977; 269: 832-33.
79. Psurek A, Neusüss C, Degenkolb T, et al. Detection of new amino acid sequences of alamethicins F30 by non aqueous capillary electrophoresis mass spectrometry. J Peptide Sci 2006; 12: 279-90.
80. Kirschbaum J, Krause C, Winzheimer R K, Brückner H. Sequences of alamethicins F30 and F50 reconsidered and reconciled. J Peptide Sci 2003; 9: 799-809.
81. Fox RO, Richards FM. A voltage-gated ion channel inferred from the crystal structure of alamethicin at 1.5 _ resolution. Nature 1982; 300: 325-30.
82. Franklin JC, Ellena JF, Jayasinghe S, Kelsh LP, Cafiso DS. Structure of micelleassociated alamethicin from 1H NMR. Evidence for conformational heterogeneity in a voltage-gated peptide. Biochemistry 1994; 33: 4036-45.
83. Huang HW, Wu Y. Lipid-alamethicin interactions influence alamethicin orientation. Biophys J 1991; 60: 1079-87.
84. Quay S C, Latorre R. Molecular mechanisms of alamethicin channel gating. Biophys J 1981; 37: 154-6.
85. Barranger-Mathys M, Cafiso DS. Membrane structure of voltagegated channel forming peptides by site-directed spin-labeling. Biochemistry 1996; 35: 498-505.
86. Boheim G. Statistical analysis of alamethicin channels of black lipid membranes. J Membr Biol 1974; 19: 277-303.
87. Sackmann B, Boheim G. Alamethicin-induced single channel conductance in biological membranes. Nature 1979; 282: 336-9.
88. Hall JE, Vodyanoy I, Balasubramanian TM, Marshall GR. Alamethicin. A rich model for channel behavior. Biophys J 1984; 45: 233-47.
89. Duclohier H, Wroblewski H. Voltage-dependent pore formation and antimicrobial activity by alamethicin and analogues. J Membrane Biol 2001; 184: 1-12.
90. Mueller P, Rudin DO. Action potentials induced in biomolecular lipid membranes. Nature 1968; 217: 713-9.
91. Duclohier H, Spach G. Artificial membrane excitability revisited and implications for the gating of voltage-dependent ion channels. Gen Physiol Biophys 2001; 20: 361-74.
92. Montal M, Mueller P. Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad Sci USA 1972; 69: 3561-6.
93. Hanke W, Schlue WR. Planar Lipid Bilayers, Methods and applications. biological techniques series. San Diego: Academic Press 1993.
94. Laver DR. The barrel-stave model as applied to alamethicin and its analogs reevaluated. Biophys J 1994; 66: 355-9.
95. Ladha S, Mackie AR, Harvey LJ, et al. Lateral diffusion in planar lipid bilayers: a fluorescence recovery after photobleaching investigation of its modulation by lipid composition, cholesterol, or alamethicin content and divalent cations. Biophys J 1996; 71: 1364-73.
96. Helluin O, Dugast JY, Molle G, et al. Lateral diffusion and conductance properties of a fluorescein-labelled alamethicin in planar lipid bilayers. Biochim Biophys Acta 1997; 1330: 284-92.
97. Leitgeb B, Szekeres A, Manczinger L, Vagvölgyi C, Kredics L. The history of alamethicin: a review of the most extensively studied peptaibol. Chem Biodiver 2007; 4: 1037-51.
98. Merrifield B. Concept and early development of solid-phase peptide synthesis. Methods Enzymol 1997; 289: 3-13.
99. Haris PI, Molle G, Duclohier H. Conformational changes in alamethicin associated with substitution of its alpha-methylalanines with leucine: a FTIR spectroscopic analysis and correlation with channel kinetics. Biophys J 2004; 86: 248-53.
100. Molle G, Duclohier H, Dugast JY, Spach G.Design and conformation of non-Aib synthetic peptides enjoying alamethicin-like ionophore activity. Biopolymers 1989; 28: 273-83.
101. Molle G, Duclohier H, Julien S, Spach G. Synthetic analogues of alamethicin: effect of C-terminal residue substitutions and chain length on the ion channel lifetimes. Biochim Biophys Acta 1991; 1064: 365-9.
102. Duclohier H, Molle G, Dugast JY, Spach G. (1992). Prolines are not essential residues in the "barrel-stave" model for ion channels induced by alamethicin analogues. Biophys J 1992; 63: 868-73.
103. Kaduk C, Duclohier H, Dathe M, et al. Influence of proline position upon the ion channel activity of alamethicin. Biophys J 1997; 72: 2151-9.
104. Molle G, Dugast JY, Spach G, Duclohier H. Ion channel stabilization of synthetic alamethicin analogs by rings of inter-helix Hbonds. Biophys J 1996; 70: 1669-75.
105. Breed J, Kerr ID, Molle G, Duclohier H, Sansom MS. Ion channel stability and hydrogen bonding. Molecular modelling of channels formed by synthetic alamethicin analogues. Biochim Biophys Acta 1997; 1330: 103-9
106. You S, Peng S, Lien L, Breed J, Sansom MS, Wolley GA. Engineering stabilized ion channels: covalent dimers of alamethicin. Biochemistry 1996; 35: 6225-32.
107. Okazaki T, Sakoh M, Nagaoka Y, Asami K. Ion channels of alamethicin dimer Nterminally linked by disulfide bond. Biophys J 2003, 85: 267-73.
108. Starostin AV, Butan R, Borisenko V, et al. An anion-selective analogue of the channel-forming peptide alamethicin. Biochemistry 1999; 38: 6144-50.
109. Duclohier H, Kociolek K, Stasiak M, Leplawy MT, Marshall GR. C-terminally shortened alamethicin on templates: influence of the linkers on conductances. Biochim Biophys Acta 1999; 1420: 14-22.
110. Duclohier H, Alder G, Kociolek K, Leplawy MT. Channel properties of template assembled alamethicin tetramers. J Pept Sci 2003; 9: 776-83.
111. Hou CT, Ciegler A, Hesseltine CW. New mycotoxin, trichotoxin A, from Trichoderma viride isolated from southern leaf blight-infected corn. Appl Microbiol 1972; 23: 183-5.
112. Chugh JK, Wallace BA. Peptaibols: models for ion channels. Biochem Soc Trans 2001; 29: 565-70. (See also http://www.cryst.bbk.ac.uk/peptaibols/).
113. Chugh JK, Brückner H, Wallace BA. Model for a helical bundle channel based on the high-resolution crystal structure of trichotoxin_ A50E. Biochemistry 2002; 41: 12934-41.
114. Brückner H, Przybylski M. Isolation and structural characterization of polypeptide antibiotics of the peptaibol class by high performance liquid chromatography with field desorption and fast atom bombardment mass spectrometry. J Chromatogr 1984; 296: 263-75.
115. Duclohier H, Alder GM, Bashford CL, Brückner H, Chugh JK, Wallace BA. Conductance studies on trichotoxin_A50E and implications for channel structure. Biophys J 2004; 87: 1705-10.
116. Jaworski A, Brückner H. New sequences and new fungal producers of peptaibol antibiotics antiamoebins. J Peptide Sci 2000; 6: 149-67.
117. Karle IL, Perozzo MA, Mishra VK, Balaram P. Crystal structure of the channelforming polypeptide antiamoebin in a membranemimetic environment. Proc Natl Acad Sci USA 1998; 95: 5501-4.
118. Snook CF, Wolley GA, Oliva G, et al. The structure and function of antiamoebin I, a proline-rich membrane-active polypeptide. Structure 1998; 6: 783-92.
119. Duclohier H, Snook CF, Wallace BA. Antiamoebin can function as a carrier or as a pore-forming peptaibol. Biochim Biophys Acta 1998; 1415: 255-60.
120. O'Reilly AO, Wallace BA. (2003). The peptaibol antimoebin as a model ion channel: similarities to bacterial potassium channels. J Pept Sci 2003; 9: 769-75.
121. Duclohier H. Helical kink and channel behaviour: a comparative study with the peptaibols alamethicin, trichotoxin and antiamoebin. Eur Biophys J 2004; 33: 169-74.
122. Ri Y, Ballessteros JA, Abrams CK, et al. The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys J 1999; 76: 2887-98.
123. Law RJ, Tieleman DP, Sansom MS. Pores formed by the nicotinic receptor m2delta peptide: a molecular dynamics simulation study. Biophys J 2003; 84: 14-27.
124. Helluin O, Bendahhou S, Duclohier H. Voltage sensitivity and conformational change of isolated S4L45 fragments are tuned to proline. Eur Biophys J 1998; 27: 595-604.
125. El Hajii M, Rebuffat S, Lecommandeur D, Bodo B. Isolation and sequence determination of trichorzianines A antifungal peptides from Trichoderma harzianum. Int J Pept Protein Res 1987; 29: 207-15.
126. Duclohier H, Molle G, Spach G. The influence of the trichorzianin C-terminal residues on the ion channel conductance in lipid bilayers. Biochim Biophys Acta 1989; 987: 133-6.
127. Krause C, Kirschbaum J, Jung G, Brückner H. Sequence diversity of the peptaibol antibiotic suzukacillin A from the mold Trichoderma viride. J Peptide Sci 2006; 12: 312-27.
128. Jung G, König WA, Leibfritz D, Ooka T, Janko K, Boheim G. Structural andmembrane modifying properties of suzukacillin, a peptide antibiotic related to alamethicin. Part A. Sequence and conformation. Biochim Biophys Acta 1976; 433: 164-181.
129. Boheim G, Janko K, Leibfritz D, Ooka T, König WA, Jung B. Structural and membrane modifying properties of suzukacillin, a peptide antibiotic related to alamethicin. Part B. Pore formation in black lipid films. Biochim Biophys Acta 1976; 433: 182-99.
130. Akasaki K, Karasawa K, Watanabe M, Yonehara H, Umezawa H. Monazomycin, a new antibiotic produced by a Streptomyces. J Antibiot (Tokyo) 1963; 16: 127-31.
131. Andersen OS, Muller RU. Monazomycin-induced single-channels. I. Characterization of the elementary conductance events. J Gen Physiol 1982; 80: 403-26.
132. Rebuffat S, Goulard C, Bodo B. (1995). Antibiotic peptides from Trichoderma harzianum: harzianins HC, proline-rich 14-residue peptaibols. J Chem Soc Perkin Trans 1995; 1: 1849-55.
133. Wiest A, Grzegorski D, Xu BW, et al. Identification of peptaibols from Trichoderma virens and cloning of a peptaibol synthetase. J Biol Chem 2002; 277: 20862-8.
134. Lucaciu M, Rebuffat S, Goulard C, Duclohier H, Molle G, Bodo B. Interaction of the 14-residue peptaibols, harzianins HC, with lipid bilayers: permeability modifications and conductance properties. Biochim Biophys Acta 1997; 1323: 85-96.
135. Béven L, Helluin O, Molle G, Duclohier H, Wroblewski H. Correlation between anti-bacterial activity and pore sizes of two classes of voltage-dependent channelforming peptides. Biochim Biophys Acta 1999; 1421: 53-63.
136. Duquesne S, Petit V, Peduzzi J, Rebuffat S. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. J Mol Microbiol Biotechnol 2007; 13: 200-9.
137. Leclerc G, Goulard C, Prigent Y, Bodo B, Wroblewski H, Rebuffat S. Sequences and antimycoplasmic properties of longibrachins LGB II and LGB III, two novel 20-residue peptaibols from Trichoderma longibrachiatum. J Nat Prod 2001; 64: 164-70.
138. Lienkamp K, Tew GN. Synthetic mimics of antimicrobial peptides- A versatile ring-opening metathesis based platform for the synthesis of selective and cellpenetrating polymers. Chem Eur 2009; 15: 11784-800.
139. Fassi F, Wroblewski H, Blanchard A. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob Agents Chemother 2007; 51: 468-74.
140. Marcellini L, Borro M, Gentile G, et al. Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. FEBS J 2009; 276: 5647-64.
141. Ahmad A, Azmi S, Srivastava RM, et al. Design of non-toxic analogs of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine sequences in determining its toxicity. Biochemistry 2009; 48: 10905-17.
142. Haney EF, Nathoo S, Vogel HJ, Prenner EJ. Induction of nonlamellar lipid phases by antimicrobial peptides: a potential link to mode of action. Chem Phys Lipid 2010; 163: 82-93.
143. Angelova A, Ionov R, Koch MHJ, Rapp G. Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. Arch Biochem Biophys 2000; 378: 93-106.
144. Holt A, Killian JA. Orientation and dynamics of transmembrane peptides: the power of simple models. Eur Biophys J 2010; 39: 609-21.
145. Niyonsaba F, Nagaoka I, Ogawa H, Okumura K. Multifunctional antimicrobial proteins and peptides: natural activators of the immune systems. Curr Pharm Des 2009; 15: 2393-413.
146. Zhang L, Falla TJ. Potential therapeutic application of host defense peptides. Methods Mol Biol 2010; 618: 303-27.
147. Liu L, Xu K, Wang H, et al. Self assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotechnol 2009; 4: 457-63.
148. Pathan F, Venkata DA, Panguluri SK. Recent patents on antimicrobial peptides. Recent Pat. DNA Gene Seq 2010; 4: 10-16.
149. Dressel S, Harder J, Cordes J, et al. Differential expression of antimicrobial peptides in margins of chronic wounds. Exp Dermatol 2010; 19(7): 628-32.
150. Degenkolb T, Gräfenhan T, Nirenberg H.I, Gams W, Brückner H. Trichoderma brevicompactum complex: rich source of novel and recurrent plant protective polypeptide antibiotics (peptaibols). J Agr Food Chem 2006; 54: 7047-61.
151. Andersson MA, Mikkola R, Raulio M, Kredics L, Maijala P, Salkinoja-Salonen MS. Acrebol, a novel toxic peptaibol produced by an Acremoniumexuvarium indoor isolate. J Appl Microbiol 2009; 106: 909-23.
152. Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009; 15(21): 2377-92.
153. Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM. Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr Pharm Des 2004; 10(23): 2891-905.
154. Sitaram N, Nagaraj R. Host-defense antimicrobial peptides: importance of structure for activity. Curr Pharm Des 2002; 8(9): 727-42.